Cite
HARVARD Citation
Byun, J. et al. (2022). A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC). Expert opinion on pharmacotherapy. pp. 1247-1257. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Byun, J. et al. (2022). A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC). Expert opinion on pharmacotherapy. pp. 1247-1257. [Online].